Zevin Asset Management Llc
Source: SEC Form 13F · as of Mar 2026Zevin Asset Management Llc holds 11 biotech & pharma companies tracked by BioSniper, totaling $59.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$59.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 81,849 | $17.8M |
| LLYELI LILLY & Co | 13,737 | $12.6M |
| AZNASTRAZENECA PLC | 63,310 | $12.5M |
| NVSNovartis AG | 79,087 | $12.1M |
| AMGNAMGEN INC | 3,256 | $1.1M |
| ABTABBOTT LABORATORIES | 9,869 | $1.0M |
| MRKMerck & Co., Inc. | 5,318 | $640K |
| GILDGILEAD SCIENCES, INC. | 4,006 | $558K |
| PFEPFIZER INC | 14,641 | $411K |
| JNJJOHNSON & JOHNSON | 1,038 | $254K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,647 | $201K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.